The conundrum of time trends in stroke Catharine R Gale BSc Christopher N Martyn DPhil FRCP J R Soc Med 1997;90: [138] [139] [140] [141] [142] [143] We tend to think of stroke and coronary heart disease (CHD) as two sides of the same coin. The International Classification of Diseases groups them both as diseases of the circulatory system. They share several risk factors including hypertension, cigarette smoking, and diabetes. And it is widely accepted that atherosclerosis plays an important part in their pathogenesis. But there are notable, though often ignored, differences in their epidemiology. The worldwide geographical distribution of the two diseases is quite dissimilar; the large male excess in the risk of CHD, particularly at younger ages, is not seen in stroke; and while plasma cholesterol concentration is a powerful predictor of CHD, the evidence that it affects the risk of stroke is less clear-cut. But perhaps the most striking inconsistency between the two diseases lies in their time trends.
LONG-TERM TRENDS IN STROKE MORTALITY
One of the most interesting features of the epidemiology of stroke is the very steep decline in mortality that has occurred in many countries. In England and Wales, for example, death rates from stroke have been falling since the early part of this century (Figure 1) . The pattern is similar in the USAI. In other western and northern European countries the decline began rather later, but most industrialized countries have experienced a decrease in stroke mortality since the early 1950s and an acceleration of the decline since the start of the 1970s2,3. It is worth emphasizing how rapidly mortality from stroke has changed. Between 1970 and 1985, rates in both men and women fell by over 50% in Japan, the USA, Australia and Israel, and most other countries saw falls of over 30%3X4.
There are a few irregularities in this pattern of widespread decline in stroke mortality. In some of the countries of eastern Europe, where death rates from stroke have been high for as long as records have been kept, mortality has remained stable or even increaseds. In Poland and Hungary, for example, stroke mortality among men rose by more than 50% between 1970 and 19852,3.
DIFFERENCES BETWEEN MORTALITY TRENDS IN STROKE AND CHD
The decline in mortality from stroke seen in many countries over the past few decades is conspicuously different from Wales, 1901 Wales, -1990 Wales, (1950 the trends in mortality from CHD. Despite the uncertainties about mortality from CHD in the early part of the century, when statistics did not distinguish between death from CHD and deaths from other forms of heart disease, it is clear that the trends in mortality of CHD and stroke began to diverge from around 190068. Figure 2 shows death rates from heart disease and stroke among men in the USA between 1900 and 1940. Mortality from stroke began to fall at the start of this period while mortality from heart disease increased steeply from 1920. This rise continued for the next 30 years and death rates did not industrialized countries, men experienced increasing mortality from CHD until the 1970s, while stroke mortality continued to fall3'9. The extent of the difference in the time trends between CHD and stroke in the middle years of the century is illustrated in Figure 3 , which shows the percentage change in death rates among men for these two diseases in various countries between 1952 and 1967. By the early 1980s, most countries, with the exception of those in eastern Europe, were seeing falls in death rates from both coronary heart disease and stroke; but, even though the trends of the two diseases were no longer divergent, rates of decline tended to be greater for stroke4 ( Figure 4 ). In France, for instance, mortality from stroke in men declined by 46% between 1970 and 1985, while mortality from CHD fell by only 9%.
DEFICIENCIES OF MORTALITY DATA
What reasons might underlie the long-term and progressive decline in rates of death from stroke? Mortality statistics are, of course, ultimately derived from what medical practitioners write on death certificates. They are prone to various biases and inaccuracies, and interpretation of trends in mortality is complicated by the possibility that they are influenced by changes in diagnostic habits, classification procedures or certification practice. Yet the magnitude of the decline in stroke mortality, its persistence over a long period of time and the occurrence of a similar pattern in so many countries prevent it being dismissed as artefactual. Q=stroke; *=coronary heart disease
INCIDENCE OF STROKE
Even so, it would be reassuring to validate the trends in mortality by comparing them with trends in incidence.
Unfortunately, no such information exists for the early decades of the century, and even for recent years reliable data on trends in the incidence of stroke are sparse and mainly based on small populationsl. The best of the longterm studies is from Rochester, Minnesota, where rates of stroke have been monitored since 194511-13. Here, the incidence of stroke declined by 60% between 1945-1949 and 1970-1974. In the same period, mortality fell by 67%, which suggests that it reflects the underlying rate of disease fairly accurately. Comparison of recent data concerning incidence and mortality shows less agreement. After 1975, the incidence of stroke in Rochester, Minnesota, actually increased slightly. This rise coincided with the increasing availability of non-invasive brain imaging techniques and the apparent increase may be attributable to improved ascertainment of milder cases14. Several other studies have been conducted in countries where mortality has been falling and most indicate that incidence has also been falling1 20. In others, rates have remained stable21-24 or have risen slightly25'26, though, in the latter, the trends have not been consistent in all age groups or both sexes. In eastern Europe, where stroke mortality has been rising in recent years, incidence rates too have increased27-29.
Although the trends of mortality and incidence seem generally to be moving in the same directions, there are 139 k\\,\\\\\\, 1\ \ \ M exceptions and there is some evidence that mortality is falling faster than incidence. One reason for this might be that survival rates have improved. Studies in Rochester, Sweden, Finland, China and New Zealand provide some support for this notiont2'15'17'212326. In Rochester, for example, the 30-day case fatality rate decreased by almost 50% between 1945-1949 and 1980-198412. Some of the recent studies discussed above15-17 are early results from the WHO MONICA Project, which was set up in the early 1980s to investigate trends in stroke and CHD in 21 populations over a 10 year period. By establishing registers with standardized criteria for case ascertainment and classification of events and by validating official mortality data against these registers, the MONICA Project is likely to provide more accurate estimates of trends in incidence and case fatality than can be obtained from routinely collected statistics, and should soon throw new light on the factors underlying recent trends in stroke mortality30.
CAN THE TRENDS IN MORTALITY BE EXPLAINED BY CHANGES IN RISK FACTORS?
Comparison of mortality data shows striking discrepancies between the time trends of stroke and CHD. The long-term downward trend in stroke mortality stands in contrast to the rise and fall in deaths from coronary heart disease. Some data are available that allow us to quantify how much of the trends in mortality can be accounted for by changes over time in the prevalence of known risk factors. High blood pressure, of course, is an important modifiable risk factor for stroke and the idea that the accelerated decline in death rates is attributable to the growing use of anti-hypertensive drugs is appealing to physicians3l. But quantitative studies do not support this explanation. The National Health and Nutrition Surveys in the USA estimated that, of people aged between 35 and 74 years, 6 million more were receiving anti-hypertensive treatment in 1980 than in 1970. In the same decade, mortality from stroke fell by 40%. However, mean diastolic blood pressure in survey participants declined by only 1 mmHg during this period, and the results of a pooled analysis of nine randomized controlled trials of anti-hypertensive drugs, together with observations from the Framingham study and the Multiple Risk Factor Intervention Trial, indicate that, at most, a quarter of the decline can be explained by better treatment of high blood pressure32. In New Zealand, stroke mortality fell by 36% between 1973 and 1982, but improvements in the detection and treatment of hypertension were estimated to account for only 10% of this decline33. Further, a comparison of age-sex-race groups in the US showed that the average annual decline in stroke mortality between 1973 and 1981 was similar among the different groups, despite the great 140 n soiumintae i abot 105 m Hg4, toughsom variation between them in the treatment and control of hypertension34. Anti-hypertensive treatment can have played no part in the decline in stroke mortality before 1950. And, with the benefit of hindsight, expectations that it would play a major role in the prevention of stroke deaths in subsequent years were unrealistic. While it is true that, in a population, individuals at the upper end of the frequency distribution of blood pressure are at greatest risk of stroke, it must be remembered that the majority of strokes occur in people in the middle of the distribution whose blood pressure is below the cut-off for treatment35. In the USA, for example, Klag and co-workers estimated that less than half the strokes in 1980 could be attributed to hypertension (defined as a systolic pressure of >160 mm Hg)36. No strategy, however successful, based on treating people at greatest risk could account for the magnitude of the observed decline in stroke mortality.
On the other hand, shifting the blood pressure distribution of a population can have a profound effect. In Finland, between 1972 and 1992, mean diastolic blood pressure decreased by between 9 and 12 mm Hg, and during this period stroke mortality fell by over 60%. The change in blood pressure seemed to account for around half the decline in death rates37.
One factor that may have played a part in this fall in blood pressure, and hence the decline in stroke mortality, is salt intake. Ecological studies have shown that populations with a high salt intake tend to have high rates of stroke38 and there is now considerable evidence from experimental and observational studies that a high intake of dietary salt has an adverse effect on blood pressure. In a recent study of chimpanzees, a species phylogenetically closer to human beings than the usual rat model, salt was added in increasing amounts, up to about 300mmol sodium per day, to the experimental group's normal low-sodium high-potassium fruit and vegetable diet39. After 84 weeks their mean blood pressure was higher by 33 / 10 mm Hg, but it fell to baseline after the animals resumed their normal diet. In contrast, the control group showed no rise in blood pressure over time.
Studies of rural Kenyans, who traditionally follow a low sodium diet, showed that those who migrated to urban communities experienced an increase in blood pressure after adopting a higher salt diet40. Results from the INTERSALT study of 52 populations in 32 countries aged 20-59 have shown strong positive associations between urinary sodium excretion, the best estimate of salt intake, and systolic blood pressure, and suggest that a habitual high salt intake may be responsible for the rise in blood pressure with age that is seen in most populations41'42. The INTERSALT investigators calculate that, at age 55, the blood pressure difference for a 100 mmol per day difference in sodium intake is about 10/ 5 mm Hg 42 , though some commentators suggest that this may be an overestimate of the size of the effect43. There are no data from randomized trials on the effects of changing salt intake on risk of cardiovascular disease, but results from prospective observational studies suggest that a long-term difference of 5-6 mm Hg in diastolic blood pressure is associated with a 35-40% reduction in risk of stroke and a 20-25% reduction in risk of coronary heart disease44. Unfortunately, we have no accurate information on trends over time in salt consumption, so it is impossible to estimate how much changes in salt intake have contributed to the long-term decline in stroke mortality by influencing blood pressure.
Cigarette smoking has only lately come to be recognized as a risk factor for stroke45, though its effect on risk of coronary heart disease has been clearly established for many years. Trends in the prevalence of smoking in many Western countries show similarities with those of CHD mortality, but are far less well matched with the trends in stroke. In Britain and the USA, for example, the popularity of smoking continued to increase steadily for many years after death rates from stroke had started their downward fall.
Raised serum cholesterol concentrations have also been strongly associated with coronary heart disease, but studies on their relation with stroke have produced conflicting results. A recent meta-analysis found no significant association between cholesterol and risk of stroke46. But in a Finnish study, cholesterol concentrations did seem to influence stroke mortality in men. Reduction in average serum concentrations of cholesterol was estimated to account for 16% of the fall in mortality from stroke over a 20 year period37. CONCLUSION Changes in the prevalence of known risk factors for vascular disease provide only a partial explanation for the decline in stroke mortality. And the striking differences between the trends in mortality from stroke and coronary heart disease suggest that the causation of these two diseases cannot be identical. If we are to decipher the enigma of the long-term decline in stroke death rates, we may need to look beyond established risk factors for atherosclerotic disease. Several intriguing new ideas are emerging. Over the past few years, evidence has accumulated that cardiovascular disease may be a delayed consequence of impaired growth in early life. People who were small at birth or who grew poorly in infancy have an increased risk of both CHD and stroke in adult life47-50.
Another area of growing interest is the possibility that dietary antioxidants, such as vitamin C, vitamin E and #carotene, are implicated in the aetiology of cardiovascular disease. Antioxidant vitamins protect low density lipoprotein from oxidation, and a high dietary intake might help to prevent not only the initiation and progression of atherosclerotic lesions, but also the resulting clinical events51. Results from prospective studies suggest that a high intake of vitamin E reduces the risk of coronary heart disease, and further support for the idea has started to emerge from randomized controlled trials of vitamin supplementation52'53. There is epidemiological evidence that people who eat a diet rich in fruit and vegetables have a lower risk of CHD though it is not yet clear whether the benefits associated with this eating pattern are attributable to the antioxidants, vitamin C and fl-carotene, or to other factors. Data on the effects of long-term supplementation with vitamin C are not yet available, but the results of trials of f-carotene have so far been disappointing54.
There have been fewer epidemiological studies into the relation between stroke and antioxidant vitamins. Whether vitamin E affects risk of stroke is, as yet, unknown. As with CHD, risk appears to be reduced in those with a high intake of fruit and vegetables. In Britain, rates of stroke are highest in regions where consumption of fruit and vegetables is lowest55. Several prospective studies have reported that diets high in vitamin C and f-carotene protect against stroke56'57, but no reduction in stroke risk was found in a 12-year trial of supplementation with fl-carotene54. One reason for the decline in mortality from both stroke and coronary heart disease in recent years may be increased consumption of vitamin C, both as supplements and as fresh fruit and vegetables58. We must await the results of the long-term trials of vitamin C supplementation to gauge whether this explanation is correct.
Another possibility is raised by research into the effects of infectious agents. Since early this century there have been reports that various infections may be linked to the development of cardiovascular disease. In recent years, epidemiological and experimental studies have provided more substantive evidence that dental infections, or respiratory and gastrointestinal infections such as Chlamydia pneumoniae and Helicobacter pylori, may increase the risk of stroke or coronary heart disease5962. The decline of infectious diseases over the course of the century parallels the decline in stroke mortality.
A recent issue of Science devoted to progress in research in cardiovascular disease contained an editorial by Nobel prizewinners Michael Brown and Joseph Goldstein. They prophesied that 'exploitation of recent breakthroughs . . . may well end coronary disease as a major public health problem early in the next century'. Their confidence may be unjustified. One lesson of the time trends of stroke is that there is still much to understand about factors that determine whether atherosclerosis manifests itself clinically as disease of coronary or cerebral arteries.
